Tuesday, March 19, 2013
ATP lV effect on your medical insurance
New NCEP ATP lV guidelines will be coming out soon.
Medical nihilists may be skeptical that it is all built on a house of cards, but it will affect everyone in the USA as to what their medical insurance pays for.
How often to get lipid panel while on treatment.
How to dose statins, whether to target number goals such as LDL-C > 70 or doses according to the best random controlled trials with primary positive outcomes.
Will advanced lipid testing be paid for such Lp (a)?
Will CIMT or CAC be paid for?
Will statin therapy start earlier for lower risk category, 1-5% Framingham risk score?
Read article below for my opinions.
Go to site:
Response to Tom Naughton about Big Pharma influence on drug trials
and how ATP lV is trying to distance themselves from that influence. I bet Niasapan and Zetia will not be in the main guidelines as there are no RCT with positive primary outcomes for them.
Posted by Brian Scott Edwards MD at 2:36 AM